On Wednesday, AI video synthesis firm Runway and entertainment company Lionsgate announced a partnership to create a new AI model trained on Lionsgate’s vast film and TV library. The deal will feed Runway legally clear training data and will also reportedly provide Lionsgate with tools to enhance content creation while potentially reducing production costs.
Lionsgate, known for franchises like John Wick and The Hunger Games, sees AI as a way to boost efficiency in content production. Michael Burns, Lionsgate’s vice chair, stated in a press release that AI could help develop “cutting edge, capital efficient content creation opportunities.” He added that some filmmakers have shown enthusiasm about potential applications in pre- and post-production processes.
Runway plans to develop a custom AI model using Lionsgate’s proprietary content portfolio. The model will be exclusive to Lionsgate Studios, allowing filmmakers, directors, and creative staff to augment their work. While specifics remain unclear, the partnership marks the first major collaboration between Runway and a Hollywood studio.
“We’re committed to giving artists, creators and studios the best and most powerful tools to augment their workflows and enable new ways of bringing their stories to life,” said Runway co-founder and CEO Cristóbal Valenzuela in a press release. “The history of art is the history of technology and these new models are part of our continuous efforts to build transformative mediums for artistic and creative expression; the best stories are yet to be told.”
The quest for legal training data
Generative AI models are master imitators, and video synthesis models like Runway’s latest Gen-3 Alpha are no exception. The companies that create them must amass a great deal of existing video (and still image) samples to analyze, allowing the resulting AI models to re-synthesize that information into new video generations, guided by text descriptions called prompts. And wherever that training data is lacking, it can result in unusual generations, as we saw in our hands-on evaluation of Gen-3 Alpha in July.
